Monopar Therapeutics
MNPR
#7582
Rank
S$0.62 B
Marketcap
S$92.69
Share price
-0.94%
Change (1 day)
-6.60%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -S$22.99 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$17.66 Million, an increase over its 2024 earnings that were of -S$20.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$22.99 Million30.19%
2025 -S$17.66 Million-11.99%
2024 -S$20.07 Million85.5%
2023 -S$10.82 Million-20.1%
2022 -S$13.54 Million15.52%
2021 -S$11.72 Million44.39%
2020 -S$8.12 Million49.23%
2019 -S$5.44 Million28.04%
2018 -S$4.25 Million-80.07%
2017 -S$21.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA